Experiences with
Cyclophosphamide1,139 public posts
Median PFS for FCR treated CLL patients with IGHV-M was 14.6 years vs 4.2 years for patients with IGHV-UM. V+O and I+R look to be superior
An update of the long-term follow-up results from the original 300-patient FCR (fludarabine, cyclophosphamide, and rituximab) study initiated at MD Anderson in 1999, Sustained remissions in CLL after frontline FCR treatment with very-long-term follow-up, reports ~47% of patients with mutated IGHV
Want to take advantage of all our features? Just log in!
or
A tunnelling ulcer in Sweet's syndrome after chemotherapy
He had received immune-chemotherapy with a BV-CHP regimen, including brentuximab vedotin (BV, 1.8 mg/kg on day 1), cyclophosphamide (750 mg/m2 on day 1), doxorubicin (50 mg/m2 on day 1), and prednisone (100 mg on days 1–5) (4) for four cycles and achieved complete remission (CR) during the second cycle